Recombinant Activated Factor VII in Aortic Surgery for Patients Under Hypothermic Circulatory Arrest

References

• Gupta P, Harky A, Jahangeer S, Adams B, Bashir M. Varying evidence on deep hypothermic circulatory arrest in thoracic aortic aneurysm surgery. Tex Heart Inst J. 2018;45(2):70–75. doi:10.14503/THIJ-17-6364
   PubMed Web of Science ®Google Scholar
• Keenan JE, Wang H, Gulack BC, et al. Does moderate hypothermia really carry less bleeding risk than deep hypothermia for circulatory arrest? A propensity-matched comparison in hemiarch replacement. J Thorac Cardiovasc Surg. 2016;152(6):1559–1569.e2. doi:10.1016/j.jtcvs.2016.08.014
   PubMed Web of Science ®Google Scholar
• Kamiya H, Hagl C, Kropivnitskaya I, et al. The safety of moderate hypothermic lower body circulatory arrest with selective cerebral perfusion: a propensity score analysis. J Thorac Cardiovasc Surg. 2007;133(2):501–509. doi:10.1016/j.jtcvs.2006.09.045
   PubMed Web of Science ®Google Scholar
• Keeling WB, Tian DH, Leshnower BG, et al. Safety of moderate hypothermia with antegrade cerebral perfusion in total aortic arch replacement. Ann Thorac Surg. 2018;105(1):54–61. doi:10.1016/j.athoracsur.2017.06.072
   PubMed Web of Science ®Google Scholar
• Harrington DK, Lilley JP, Rooney SJ, Bonser RS. Nonneurologic morbidity and profound hypothermia in aortic surgery. Ann Thorac Surg. 2004;78(2):596–601. doi:10.1016/j.athoracsur.2004.01.012
   PubMed Web of Science ®Google Scholar
• Ise H, Kitahara H, Oyama K, et al. Hypothermic circulatory arrest induced coagulopathy: rotational thromboelastometry analysis. Gen Thorac Cardiovasc Surg. 2020;68(8):754–761. doi:10.1007/s11748-020-01399-y
   PubMed Web of Science ®Google Scholar
• Al Douri M, Shafi T, Al Khudairi D, et al. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis. 2000;11(Suppl 1):S121–S127. doi:10.1097/00001721-200004001-00023
   PubMed Web of Science ®Google Scholar
• Yank V, Tuohy CV, Logan AC, et al. Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications Vs. Usual Care. Rockville (MD): Agency for Healthcare Research and Quality (US); Report No.: 10-ehc030-ef. 2010.
   Google Scholar
• Gill R, Herbertson M, Vuylsteke A, et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation. 2009;120(1):21–27. doi:10.1161/CIRCULATIONAHA.108.834275
   PubMed Web of Science ®Google Scholar
• Hoffmann T, Assmann A, Dierksen A, et al. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: lessons from an observational study. J Thorac Cardiovasc Surg. 2018;156(4):1564–1573.e8. doi:10.1016/j.jtcvs.2018.03.167
   PubMed Web of Science ®Google Scholar
• Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA. Intraoperative use of recombinant activated factor VII during complex aortic surgery. J Thorac Cardiovasc Surg. 2012;143(5):1198–1204. doi:10.1016/j.jtcvs.2012.01.004
   PubMed Web of Science ®Google Scholar
• Takamoto S, Motomura N, Miyata H, Tsukihara H. Current status of cardiovascular surgery in Japan, 2013 and 2014: a report based on the Japan Cardiovascular Surgery Database (JCVSD). 1: mission and history of JCVSD. Gen Thorac Cardiovasc Surg. 2018;66(1):1–3. doi:10.1007/s11748-017-0843-4
   PubMed Web of Science ®Google Scholar
• Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363(19):1791–1800. doi:10.1056/NEJMoa1006221
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458. doi:10.1038/bmt.2012.244
   PubMed Web of Science ®Google Scholar
• Guan X, Li J, Gong M, Lan F, Zhang H. The hemostatic disturbance in patients with acute aortic dissection: a prospective observational study. Medicine. 2016;95(36):e4710. doi:10.1097/MD.0000000000004710
   PubMed Web of Science ®Google Scholar
• Davies RS, Abdelhamid M, Wall ML, Vohra RK, Bradbury AW, Adam DJ. Coagulation, fibrinolysis, and platelet activation in patients undergoing open and endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 2011;54(3):865–878. doi:10.1016/j.jvs.2011.04.010
   PubMed Web of Science ®Google Scholar
• Kurazumi H, Mikamo A, Fukamitsu G, et al. Validation of the JapanSCORE versus the logistic EuroSCORE for predicting operative mortality of cardiovascular surgery in Yamaguchi University Hospital. Gen Thorac Cardiovasc Surg. 2011;59(9):599–604. doi:10.1007/s11748-011-0784-2
   PubMedGoogle Scholar
• Haithcock BE, Shepard AD, Raman SB, Conrad MF, Pandurangi K, Fanous NH. Activation of fibrinolytic pathways is associated with duration of supraceliac aortic cross-clamping. J Vasc Surg. 2004;40(2):325–333. doi:10.1016/j.jvs.2004.04.015
   PubMed Web of Science ®Google Scholar
• Zindovic I, Sjögren J, Ahlsson A, et al. Recombinant factor VIIa use in acute type A aortic dissection repair: a multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection. J Thorac Cardiovasc Surg. 2017;154(6):1852–1859.e2. doi:10.1016/j.jtcvs.2017.08.020
   PubMed Web of Science ®Google Scholar
• Paparella D, Rotunno C, Guida P, et al. Hemostasis alterations in patients with acute aortic dissection. Ann Thorac Surg. 2011;91(5):1364–1369. doi:10.1016/j.athoracsur.2011.01.058
   PubMed Web of Science ®Google Scholar
• Tanaka M, Kawahito K, Adachi H, Ino T. Platelet dysfunction in acute type A aortic dissection evaluated by the laser light-scattering method. J Thorac Cardiovasc Surg. 2003;126(3):837–841. doi:10.1016/S0022-5223(03)00734-7
   PubMed Web of Science ®Google Scholar
• Alfirevic A, Duncan A, You J, Lober C, Soltesz E. Recombinant factor VII is associated with worse survival in complex cardiac surgical patients. Ann Thorac Surg. 2014;98(2):618–624. doi:10.1016/j.athoracsur.2014.04.126
   PubMed Web of Science ®Google Scholar
• Fitzgerald J, McMonnies R, Sharkey A, Gross PL, Karkouti K. Thrombin generation and bleeding in cardiac surgery: a clinical narrative review. [Génération de thrombine et saignements en chirurgie cardiaque: un compte rendu narratif clinique]. Can J Anaesth. 2020;67(6):746–753. [ French]. doi:10.1007/s12630-020-01609-4
   PubMed Web of Science ®Google Scholar
• Hsia CC, Chin-Yee IH, McAlister VC. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. Ann Surg. 2008;248(1):61–68. doi:10.1097/SLA.0b013e318176c4ec
   PubMed Web of Science ®Google Scholar